S e p t e m b e r 2 5 , 2 0 2 5 PALSONIFY (paltusotine) FDA Approval Forward Looking Statements This presentation contains forward-looking statements. Crinetics Pharmaceuticals, Inc. ("Crinetics," the "company," "we," "us," or "our") cautions you that all statements other than statements of historical facts contained in this presentation are forward-looking statements. Such forward-looking statements include, but are not limited to, statements regarding: the estimates relating to market size, our ability to ...